Products

Badfish Labs

Nobody is loyal to good enough.

badfishlabs.com Design / Graphic & Brand Design

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$1206.5/mo
Higher than 96% of peersNiche median $10.594999999999999/mo
Creators
Owen Grosvenor
No social account linked
Launched
23mo ago
2024-12-18 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    No bullsht. Just brilliant design.

    Dec 18, 2024 · 23mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct37%
  • Organic Search29%
  • Referrals14%
  • Social7%
  • Other14%

Countries

  • United Kingdom100%

Search

Domain authority —Domain registered 2021-07-06

KeywordMonthly volume
entr tech320

Traffic data: Vaneform

Pricing

The Assessment
£950

Trial: None · Observed 2026-11-04 · Source page

Entry price $1206.5/mo, Higher than 96% of peers; “Graphic & Brand Design” median is $10.594999999999999/mo.View pricing benchmark

Pages & changes

Tracked since 2024-12-18

Key pages

Weekly snapshots
Home
www.badfishlabs.com/ Snapshot 2026-11-04

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Badfish Labs cost?
The Assessment: £950. Observed 2026-11-04. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Badfish Labs get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Badfish Labs and what platforms does it support?
Badfish Labs is catalogued under Graphic & Brand Design: Nobody is loyal to good enough.. Supported platforms: Web.

Related products in this category

Design / Graphic & Brand Design

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.